Table of Contents
Table 5-25: Fulton
Table 5-27: Grant
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2003 | 1999 - 2003 | 2003 | 1999 - 2003 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 91 | 557.1 | 465 | 571.6 | 34 | 214.0 | 190 | 244.0 |
| Esophagus | * | # | 11 | 13.8** | * | # | 6 | 7.8** |
| Stomach | * | # | 12 | 14.7** | * | # | 5 | 6.3** |
| Colon excluding Rectum | 10 | 63.5** | 58 | 73.2 | 5 | 28.6** | 26 | 33.5 |
| Rectum and Rectosigmoid Junction | * | # | 25 | 30.5 | * | # | 8 | 10.4** |
| Liver | * | # | 4 | # | * | # | 1 | # |
| Pancreas | * | # | 12 | 14.6** | * | # | 11 | 13.7** |
| Lung and Bronchus | 20 | 125.5 | 88 | 108.3 | 10 | 64.4** | 58 | 72.2 |
| Melanoma of the Skin | * | # | 10 | 12.7** | * | # | 2 | # |
| Prostate | 19 | 112.8** | 110 | 132.7 | * | # | 18 | 24.4** |
| Urinary Bladder | 5 | 30.8** | 30 | 37.8 | * | # | 6 | 8.2** |
| Kidney and Renal Pelvis | * | # | 13 | 15.3** | * | # | 3 | # |
| Brain and Other Nervous System | * | # | 6 | 7.1** | * | # | 2 | # |
| Non-Hodgkin Lymphoma | * | # | 17 | 21.5** | * | # | 8 | 10.2** |
| Myeloma | * | # | 6 | 7.1** | * | # | 4 | # |
| Leukemia | * | # | 12 | 15.4** | * | # | 9 | 12.0** |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2003 | 1999 - 2003 | 2003 | 1999 - 2003 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 71 | 339.8 | 364 | 350.6 | 41 | 181.1 | 179 | 163.6 |
| Colon excluding Rectum | 8 | 36.2** | 45 | 39.9 | 6 | 24.3** | 28 | 23.5 |
| Rectum and Rectosigmoid Junction | * | # | 13 | 12.4** | * | # | 3 | # |
| Liver | * | # | 1 | # | * | # | 0 | # |
| Pancreas | * | # | 10 | 9.2** | * | # | 5 | 4.2** |
| Lung and Bronchus | 15 | 68.4** | 56 | 52.1 | 14 | 60.7** | 43 | 39.3 |
| Melanoma of the Skin | * | # | 9 | 10.2** | * | # | 2 | # |
| Breast | 17 | 89.7** | 105 | 103.2 | 5 | 26.2** | 24 | 23.2 |
| Cervix Uteri | * | # | 4 | # | * | # | 3 | # |
| Corpus Uteri | * | # | 17 | 17.5** | * | # | 0 | # |
| Ovary | * | # | 13 | 12.7** | * | # | 7 | 7.2** |
| Urinary Bladder | * | # | 6 | 4.9** | * | # | 5 | 4.7** |
| Kidney and Renal Pelvis | * | # | 7 | 7.0** | * | # | 3 | # |
| Brain and Other Nervous System | * | # | 4 | # | * | # | 5 | 5.8** |
| Non-Hodgkin Lymphoma | * | # | 13 | 12.2** | * | # | 6 | 5.3** |
| Myeloma | * | # | 5 | 4.4** | * | # | 2 | # |
| Leukemia | * | # | 5 | 3.9** | * | # | 9 | 7.6** |
Rates are per 100,000; Age-adjusted, 2000 US Std Population (Census P25-1130).
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, July 2006
Table of Contents
Table 5-25: Fulton
Table 5-27: Grant
